Company page
Bridgebio Oncology Therapeutics, Inc.
Bridgebio Oncology Therapeutics, Inc. (ticker: BBOT) is a public company based in the United States, specializing in oncology therapeutics. With a market capitalization of approximately $718.6 million, the company focuses on developing innovative treatments for cancer.
- Ticker
- BBOT
- Market cap
- $718.6M
- Sector
- Health Technology
- Industry
- Biotechnology